Mito-LND (Mito-Lonidamine)
Product Specifications
CAS Number
2361564-49-8
Synonyms
Mito-Lonidamine
Target
OXPHOS
Applications
Apoptosis
Smiles
O=C (NCCCCCCCCCC[P+] (C1=CC=CC=C1) (C2=CC=CC=C2) C3=CC=CC=C3) C4=NN (CC5=CC=C (Cl) C=C5Cl) C6=C4C=CC=C6.[Br-]
Molecular Formula
C43H45BrCl2N3OP
Additionnal Information
Mito-LND (Mito-Lonidamine) is an orally administered mitochondria-targeted compound that inhibits oxidative phosphorylation (OXPHOS) . This agent reduces mitochondrial bioenergetics, promotes reactive oxygen species generation, and triggers autophagic cell death in lung cancer cells.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P3361-80-ML490 100 µL
PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1, 6PF-2-K/Fru-2,6-P2ase 1, PFK/FBPase 1, 6PF-2-K/Fru-2,6-P2ase Liver Isozyme, F6PK, HL2K, MGC116715, MGC116717, PFRX) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
MBS1450997-01 0.02 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype III Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details MBS1450997-02 0.1 mg (E-Coli)
Recombinant Streptococcus agalactiae serotype III Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details MBS1450997-03 0.02 mg (Yeast)
Recombinant Streptococcus agalactiae serotype III Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details